PACS Group, Inc. PACS
50.26 USD +3.58 (+7.67%)
At closeNov 5, 2026, 4:00 AM EST
50.00 -0.26 -0.52%
Pre-market · Nov 5, 4:00 AM ET
46.57 Day range 51.68
10.31 52-week range 51.68
- YTD
- +30.92%
- 1 year
- +303.37%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.00 +17.4% upside
Now 50.26
- Target (low)
- 57.00
- Target (mean)
- 59.00
- Target (high)
- 62.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy2
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.62 | 0.62 – 0.62 | 0.572 | +8.4% | 1.56B | +14.6% | 1 |
| Next quarter | 0.66 | 0.64 – 0.69 | 0.6385 | +3.4% | 1.62B | +14.0% | 3 |
| Current year | 2.45 | 2.45 – 2.45 | 1.81 | +35.5% | 5.86B | +10.8% | 2 |
| Next year | 2.74 | 2.58 – 3.02 | 2.45 | +11.7% | 6.54B | +11.6% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 6, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| May 18, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 4, 2026 | UBS | Maintained | Buy | Buy |
| Mar 4, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 20, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 6, 2025 | Macquarie | Maintained | Outperform | Outperform |
| Jan 6, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 17, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Nov 18, 2024 | Stephens & Co. | Maintained | Overweight | Overweight |
| Oct 14, 2024 | Truist Securities | Maintained | Buy | Buy |
| Oct 9, 2024 | UBS | Initiated | — | Buy |
| Aug 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 13, 2024 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 13, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jun 28, 2024 | Macquarie | Initiated | — | Outperform |
| May 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 15, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 14, 2024 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 6, 2024 | Stephens & Co. | Initiated | — | Overweight |
| May 6, 2024 | JP Morgan | Initiated | — | Overweight |
